Dietary Impact on Sleep, Rhythms and Related Physiology

NCT ID: NCT07138313

Last Updated: 2025-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-30

Study Completion Date

2026-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sleep and metabolism are closely interconnected, and emerging evidence suggests that dietary composition may influence both sleep quality and key physiological functions such as glucose regulation, cardiovascular activity, and hormonal signaling. This study aims to investigate how a Western-style unhealthy diet versus a healthier, fiber-rich diet affects objective and subjective sleep measures, 24-hour physiological parameters, and a range of biomarkers related to cardiometabolic, neurodegenerative, and gut microbial function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Metabolism is tightly regulated by sleep and interacts bidirectionally with diet. While it is well established that insufficient or disrupted sleep can impair glucose regulation, cardiovascular function, and promote unhealthy eating behaviors that promote cardiometabolic disease, less is known about how different dietary patterns impact subjective and objective sleep parameters, as well as related physiological systems.

The study will systematically investigate how consumption of an unhealthier "Western" diet, compared to a healthier diet, affects both objective and subjective sleep parameters, as well as 24-hour heart rate and blood pressure profiles, glucose variability, and hormonal and molecular biomarkers.

The study will be conducted as a 2-condition, randomized crossover study, with assessments in the field for about a week, followed by a multi-day stay for measurements under standardized laboratory conditions. Participants will be monitored using polysomnography, and wearable devices, including for continuous glucose and heart rate parameters, with multi-compartment sampling to assess diet-mediated responses across cardiometabolic, neurodegenerative, and microbial pathways. In field and in the lab, biological samples will be collected repeatedly across the day to establish diurnal rhythms.

Cognitive performance, mood, and subjective appetite will also be evaluated. By identifying diet-driven changes in sleep and related physiological functions, this study aims to provide mechanistic insights into how nutrition impacts sleep, cardiometabolic health parameters and molecular pathways.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Diet Interventions Circadian Rhythm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will be studied in a crossover design both after a "healthy diet", and after an "unhealthy diet"
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

In the crossover condition, participants will not be briefed about what diet they will receive before the actual onset of any of the two dietary interventions

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy diet

'Low-fat dietary intervention' to be administered to participants

Group Type EXPERIMENTAL

Low-fat dietary intervention

Intervention Type OTHER

Low-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).

Unhealthier diet

'High-fat dietary intervention' to be administered to participants

Group Type EXPERIMENTAL

High-fat dietary intervention

Intervention Type OTHER

High-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low-fat dietary intervention

Low-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).

Intervention Type OTHER

High-fat dietary intervention

High-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-32 yr
* Healthy (self-reported) and not on chronic medication
* BMI 18-27 kg/m2 (and waist circumference \<102 cm), and weight stable (less than 5% body weight change in the past 6 months)
* Non-smoker and non-nicotine user
* Regular sleep-wake pattern, with sleep duration of 7-9.25 hrs per night
* Regular exercise habits the last 2 months
* Regular daily meal pattern with 3 main meals

Exclusion Criteria

* Major or chronic illness, e.g. diabetes, renal disease or inflammatory bowel disease
* Current or history of endocrine or metabolic disorders
* Psychiatric or neurological disorders (e.g. bipolar disorder, epilepsy)
* Frequent gastrointestinal symptoms
* Chronic medication
* Any sleep disorder (including recent or chronic symptoms of insomnia)
* Shift work in the preceding three months or for a long duration
* Extreme chronotype or physical activity patterns
* Time travel over two time zones in the preceding month
* Too much weight gain or weight loss in the preceding 6 months (±5% body weight in past 6 months)
* Any issues with or allergies against the provided food items
* Recent major dietary changes or adoption of specific dietary regimens
* Women who are pregnant, breastfeeding, or planning to become pregnant during the study period.
* Use of illicit drugs or substances of abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

32 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uppsala University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Cedernaes, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Uppsala University, Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonathan Cedernaes, MD, PhD

Role: CONTACT

0184710000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CircHFJC2017pt2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Behavioral Chronotype: Impact on Sleep and Metabolism
NCT03647306 ACTIVE_NOT_RECRUITING NA
Biorhythms in Metabolic Tissues
NCT03276442 UNKNOWN NA